D.A. Davidson & Co. Organon & Co. Transaction History

D.A. Davidson & Co.

$11.2 Billion
Q2 2024

A detailed history of D.A. Davidson & Co. transactions in Organon & Co. stock. As of the latest transaction made, D.A. Davidson & Co. holds 120,618 shares of OGN stock, worth $2.31 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

120,618

Previous 117,583 2.58%

Holding current value

$2.31 Million

Previous $2.21 Million 12.94%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$17.45 - $21.96 $52,960 - $66,648	3,035 Added 2.58%	120,618 $2.5 Million
Q1 2024 May 13, 2024	BUY	$13.78 - $18.8 $995,191 - $1.36 Million	72,220 Added 159.2%	117,583 $2.21 Million
Q4 2023 Feb 09, 2024	BUY	$10.95 - $17.32 $1,970 - $3,117	180 Added 0.4%	45,363 $654,000
Q3 2023 Nov 08, 2023	SELL	$16.59 - $23.77 $3,168 - $4,540	-191 Reduced 0.42%	45,183 $784,000
Q2 2023 Aug 10, 2023	SELL	$19.27 - $24.63 $15,184 - $19,408	-788 Reduced 1.71%	45,374 $944,000
Q1 2023 Apr 25, 2023	SELL	$21.42 - $32.08 $74,948 - $112,247	-3,499 Reduced 7.05%	46,162 $1.09 Million
Q4 2022 Feb 03, 2023	SELL	$23.31 - $28.61 $80,675 - $99,019	-3,461 Reduced 6.52%	49,661 $1.39 Million
Q3 2022 Nov 07, 2022	SELL	$23.4 - $34.25 $798,946 - $1.17 Million	-34,143 Reduced 39.13%	53,122 $1.25 Million
Q2 2022 Jul 28, 2022	SELL	$31.66 - $38.9 $108,435 - $133,232	-3,425 Reduced 3.78%	87,265 $2.95 Million
Q1 2022 May 12, 2022	BUY	$30.45 - $39.36 $1.12 Million - $1.44 Million	36,687 Added 67.94%	90,690 $3.17 Million
Q4 2021 Jan 31, 2022	BUY	$28.67 - $37.13 $28,956 - $37,501	1,010 Added 1.91%	54,003 $1.65 Million
Q3 2021 Nov 15, 2021	BUY	$28.63 - $35.64 $75,440 - $93,911	2,635 Added 5.23%	52,993 $1.74 Million
Q2 2021 Aug 10, 2021	BUY	$28.45 - $38.0 $1.43 Million - $1.91 Million	50,358 New	50,358 $1.52 Million

Others Institutions Holding OGN

# of Institutions

795

Shares Held

191M

Call Options Held

1.59M

Put Options Held

931K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.88B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account